BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38048228)

  • 21. CD72 negatively regulates signaling through the antigen receptor of B cells.
    Adachi T; Wakabayashi C; Nakayama T; Yakura H; Tsubata T
    J Immunol; 2000 Feb; 164(3):1223-9. PubMed ID: 10640734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of B-cell lymphoma pathogenesis.
    Küppers R
    Nat Rev Cancer; 2005 Apr; 5(4):251-62. PubMed ID: 15803153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic evidence that phosphatidylserine synthase II catalyzes the conversion of phosphatidylethanolamine to phosphatidylserine in Chinese hamster ovary cells.
    Saito K; Nishijima M; Kuge O
    J Biol Chem; 1998 Jul; 273(27):17199-205. PubMed ID: 9642289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Ezrin-Radixin-Moesin proteins as novel regulators of pathogenic B-cell receptor signaling and tumor growth in diffuse large B-cell lymphoma.
    Pore D; Bodo J; Danda A; Yan D; Phillips JG; Lindner D; Hill BT; Smith MR; Hsi ED; Gupta N
    Leukemia; 2015 Sep; 29(9):1857-67. PubMed ID: 25801911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B cell receptor-stimulated mitochondrial phospholipase A2 activation and resultant disruption of mitochondrial membrane potential correlate with the induction of apoptosis in WEHI-231 B cells.
    Katz E; Deehan MR; Seatter S; Lord C; Sturrock RD; Harnett MM
    J Immunol; 2001 Jan; 166(1):137-47. PubMed ID: 11123286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.
    Chung EY; Psathas JN; Yu D; Li Y; Weiss MJ; Thomas-Tikhonenko A
    J Clin Invest; 2012 Jun; 122(6):2257-66. PubMed ID: 22546857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
    Davis RE; Ngo VN; Lenz G; Tolar P; Young RM; Romesser PB; Kohlhammer H; Lamy L; Zhao H; Yang Y; Xu W; Shaffer AL; Wright G; Xiao W; Powell J; Jiang JK; Thomas CJ; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Johnson NA; Rimsza LM; Campo E; Jaffe ES; Wilson WH; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pierce SK; Staudt LM
    Nature; 2010 Jan; 463(7277):88-92. PubMed ID: 20054396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphatidylserine biosynthesis pathways in lipid homeostasis: Toward resolution of the pending central issue for decades.
    Kimura AK; Kimura T
    FASEB J; 2021 Jan; 35(1):e21177. PubMed ID: 33205488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignancies.
    Shain KH; Tao J
    Oncogene; 2014 Aug; 33(32):4107-13. PubMed ID: 24037527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic Targeting of the Regulatory and Catalytic Subunits of PI3Kδ in Mature B-cell Malignancies.
    Cooney JD; Lin AP; Jiang D; Wang L; Suhasini AN; Myers J; Qiu Z; Wölfler A; Sill H; Aguiar RCT
    Clin Cancer Res; 2018 Mar; 24(5):1103-1113. PubMed ID: 29246942
    [No Abstract]   [Full Text] [Related]  

  • 31. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.
    Musilova K; Mraz M
    Leukemia; 2015 May; 29(5):1004-17. PubMed ID: 25541152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphatidylserine synthase 2: high efficiency for synthesizing phosphatidylserine containing docosahexaenoic acid.
    Kimura AK; Kim HY
    J Lipid Res; 2013 Jan; 54(1):214-22. PubMed ID: 23071296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting N-myristoylation for therapy of B-cell lymphomas.
    Beauchamp E; Yap MC; Iyer A; Perinpanayagam MA; Gamma JM; Vincent KM; Lakshmanan M; Raju A; Tergaonkar V; Tan SY; Lim ST; Dong WF; Postovit LM; Read KD; Gray DW; Wyatt PG; Mackey JR; Berthiaume LG
    Nat Commun; 2020 Oct; 11(1):5348. PubMed ID: 33093447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin.
    Rink JS; Yang S; Cen O; Taxter T; McMahon KM; Misener S; Behdad A; Longnecker R; Gordon LI; Thaxton CS
    Mol Pharm; 2017 Nov; 14(11):4042-4051. PubMed ID: 28933554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation.
    Dillon SR; Mancini M; Rosen A; Schlissel MS
    J Immunol; 2000 Feb; 164(3):1322-32. PubMed ID: 10640746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The B-cell receptor in control of tumor B-cell fitness: Biology and clinical relevance.
    Casola S; Perucho L; Tripodo C; Sindaco P; Ponzoni M; Facchetti F
    Immunol Rev; 2019 Mar; 288(1):198-213. PubMed ID: 30874349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas.
    Szydlowski M; Kiliszek P; Sewastianik T; Jablonska E; Bialopiotrowicz E; Gorniak P; Polak A; Markowicz S; Nowak E; Grygorowicz MA; Prochorec-Sobieszek M; Szumera-Cieckiewicz A; Malenda A; Lech-Maranda E; Warzocha K; Juszczynski P
    Blood; 2016 Feb; 127(6):739-48. PubMed ID: 26585955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multiprotein supercomplex controlling oncogenic signalling in lymphoma.
    Phelan JD; Young RM; Webster DE; Roulland S; Wright GW; Kasbekar M; Shaffer AL; Ceribelli M; Wang JQ; Schmitz R; Nakagawa M; Bachy E; Huang DW; Ji Y; Chen L; Yang Y; Zhao H; Yu X; Xu W; Palisoc MM; Valadez RR; Davies-Hill T; Wilson WH; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Rodriguez FJ; Estephan F; Holdhoff M; Kruhlak MJ; Hewitt SM; Thomas CJ; Pittaluga S; Oellerich T; Staudt LM
    Nature; 2018 Aug; 560(7718):387-391. PubMed ID: 29925955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirement for JNK-dependent upregulation of BimL in anti-IgM-induced apoptosis in murine B lymphoma cell lines WEHI-231 and CH31.
    Takada E; Hata K; Mizuguchi J
    Exp Cell Res; 2006 Nov; 312(19):3728-38. PubMed ID: 17007835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
    Moriyama H; Yonehara S
    Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.